News | Quality Assurance (QA) | July 08, 2019

PTW to Feature New Dosimetry Technology at AAPM 2019

Offerings will include new water phantom for MR-guided radiotherapy, modular patient and machine QA systems

The Beamscan 3-D water phantom with the Varian Halcyon radiotherapy system

The Beamscan 3-D water phantom with the Varian Halcyon radiotherapy system. Image courtesy of PTW.

July 8, 2019 — At this year’s American Association of Physicists in Medicine (AAPM) show, July 14-18 in San Antonio, Texas, PTW will exhibit its full range of dosimetry solutions for magnetic resonance-guided radiotherapy (MRgRT), beam data commissioning and stereotactic quality assurance (QA).

PTW will exhibit and demonstrate its latest technology and most recent product developments including:

  • Beamscan MR 3-D water phantom – The first 3-D water phantom for MR-guided radiotherapy, according to the company, available in two models for Elekta Unity and ViewRay MRIdian. Beamscan MR 3-D is pending U.S. Food and Drug Administration (FDA) 510(k) clearance and is not available for sale in the U.S.;
  • Beamscan 3-D water phantom – Fast to set up and easy to use for all acceptance testing and commissioning needs, now available for the Halcyon system;
  • Octavius 4-D modular patient and machine QA systems – For the latest radiotherapy techniques, including Halcyon, stereotactic radiosurgery (SRS) and MRgRT. Also introducing Octavius Detector 1600 SRS for 3-D dose verification of complex SRS/SBRT (stereotactic body radiation therapy) treatment plans;
  • Ruby phantom – A new modular stereotactic verification phantom with multiple inserts for comprehensive system QA, linear accelerator (linac) QA and patient QA:
  • StarCheck arrays – High-resolution ionization chamber arrays for comprehensive, TG-142-compliant linac QA, available in three models for standard (25 x 25 cm²), large (40 x 40 cm²) and magnetic fields;
  • microSilicon diode detector – The new silicon diode detector for small photon and all electron fields; and
  • Track-it 2.0 QA data management software – Versatile, web-based QA data management software that integrates QA data from different sources, devices and sites into a single platform.

PTW is hosting a Lunch and Learn symposium for AAPM attendees on Monday, July 15. The event will feature the following presenters:

  • Jochem Wolthaus, Ph.D., a medical physicist at the University Medical Center Utrecht, will present “The Development and Experience of the first MR-compatible 3-D Scanning Water Tank for Acceptance, Commissioning and QA measurements in an MRI-LINAC”; 
  • Dan Nicewonger, a medical physicist at the MD Anderson Cancer Center in San Antonio, will present “QA Data Flow in Modern Radiotherapy Departments”; and
  • Sharon Thompson, a medical physicist from the Maimonides Cancer Center, Brooklyn, N.Y., will present “Challenges of Beam Data Collection and Validation of Halcyon during Commissioning.”

For more information: www.ptwdosimetry.com

Related Content

Non-oncology doctors’ knowledge of oncology is frequently not up to date, with risks in the communication with patients  

Getty Images

News | Radiation Oncology | September 20, 2021
September 20, 2021 — The rapid pace of developments in the oncology field, mainly brought by cancer immunotherapy, me
IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, and SCK CEN (Belgian Nuclear Research Center) announced a strategic R&D partnership to enable the production of Actinimum-225 (225Ac), a novel radioisotope which has significant potential in the treatment of cancer.
News | Radiation Oncology | September 17, 2021
September 17, 2021 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, a
Evaluation of therapeutic efficacy of drug candidates in preclinical oncology with positron emission tomography (PET)

Getty Images

Feature | PET Imaging | September 14, 2021 | By Todd Sasser, Ph.D.
With a wealth of landmark studies in Breast, Cervical, Melanoma, Prostate, Colorectal, Oesophagus, Endocrine and Lung cancer, the ESMO Congress 2021 is a clear demonstration that oncology research has once again gathered momentum after being temporarily stopped in its tracks by the outbreak of the virus

Getty Images

News | Radiation Oncology | September 13, 2021
September 13, 2021 — At the opening press conference of the ...
Comment letters on the 2022 physician fee schedule and Radiation Oncology Model urge CMS to scale back extreme cuts that jeopardize access to life-saving cancer treatments

Getty Images

News | ASTRO | September 09, 2021
September 9, 2021 — The American Society for Radiation Oncology (AS...

Image of a STING protein, courtesy of UCLA Jonsson Comprehensive Cancer Center

News | PET Imaging | September 08, 2021
September 8, 2021 — A new study from scientists at the UCLA Jonsso...
An artificial intelligence (AI) program can spot signs of lung cancer on computed tomography (CT) scans a year before they can be diagnosed with existing methods, according to research presented at the European Respiratory Society International Congress.

Diagram showing details of the lung screening experiment. Image courtesy of the European Respiratory Society/Benoit Audelan

News | Artificial Intelligence | September 08, 2021
September 8, 2021 — An artificial intell...
At the recent 2021 AAPM Meeting in July, Sun Nuclear Corporation featured its comprehensive portfolio of independent, integrated quality management solutions for radiation therapy and diagnostic imaging.
News | Quality Assurance (QA) | September 02, 2021
September 2, 2021 — At the recent 2021 AAPM Meeting